Compare DHX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHX | ORMP |
|---|---|---|
| Founded | 1991 | 2002 |
| Country | United States | United States |
| Employees | N/A | 13 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.8M | 165.3M |
| IPO Year | 2007 | 2010 |
| Metric | DHX | ORMP |
|---|---|---|
| Price | $3.73 | $4.12 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.25 | N/A |
| AVG Volume (30 Days) | ★ 341.9K | 183.5K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | N/A | ★ 412.50 |
| EPS | 0.04 | ★ 0.91 |
| Revenue | ★ $127,826,000.00 | $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.52 | N/A |
| P/E Ratio | $93.38 | ★ $4.40 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $1.44 | $1.98 |
| 52 Week High | $4.10 | $5.01 |
| Indicator | DHX | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 47.93 |
| Support Level | $2.17 | $3.83 |
| Resistance Level | $4.10 | $4.22 |
| Average True Range (ATR) | 0.31 | 0.30 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 66.67 | 17.80 |
DHI Group Inc is a provider of software products, online tools, and services that deliver career marketplaces to candidates and employers in the United States. The company operates through two reportable segments: ClearanceJobs and Dice. Its brands enable recruiters and hiring managers to search, match, and connect with skilled technologists, particularly in technology and active government security clearance, while professionals find job opportunities, job advice, and personalized data. ClearanceJobs connects security-cleared professionals with employers in a secure environment and supports engagement through messaging and live video. Dice, which generates maximum revenue, is a destination for technology and engineering talent, offering job postings across a range of technology roles.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.